Mochimganine

Mochimganine has been studied in 1 paper since 2022: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Apr 14, 2022: “Tschimganine has different targets for chronological lifespan extension and growth inhibition in fission yeast”.

Intervention

1 paper studies it1 findingUpdated

PubChemChEBI

See all 1 papers on mochimganine

At a glance

The findings reach worms or flies, none yet in people. 1 lab in 1 country.

Worms or flies: a single group. Cells, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Japan Society for the Promotion of Science
  • Cells1

What did studies of mochimganine find?

1

Studies of mochimganine measured one outcome, lifespan.

Lifespan

upin fission yeast cells1

1 study
  1. Mochimganine extends lifespan in fission yeast cells.

    “We synthesized a Tschimganine analog, Mochimganine, which extends the lifespan similar to Tschimganine but exhibits a significantly weaker growth inhibition effect.”

    Cells

    Tschimganine has different targets for chronological lifespan extension and growth inhibition in fission yeast

    Bioscience, biotechnology, and biochemistry

Latest